Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease
The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Indoxyl sulfate induced Mac-1 expression and ROS production via p38 MAPK- and NAD(P)H oxidase-dependent pathways. Accelerated cardiovascular disease is a frequent complication of CKD. Monocyte-mediated inflammation and adhesion of monocytes to vascular endothelium are key events in atherogenesis. An oral adsorbent, AST-120, retards renal function deterioration by lowering IS, which is known to accumulate in CKD patients. However, the effect of AST-120 on CKD-related monocyte activation is unknown. We aimed to determine whether AST-120 improves monocyte-mediated inflammation through IS reduction. Flow cytometric analysis showed that Mac-1 expression and ROS production were significantly higher in peripheral blood monocytes of subtotal Nx CKD mice than in sham-operated mice. AST-120 treatment significantly decreased Mac-1 expression and ROS production in CKD model mice. Furthermore, administration of IS induced monocyte-mediated inflammation and ROS generation. In vitro studies indicated that IS dose-dependently increased THP-1 monocytic cell adhesion to IL-1β-activated HUVECs under physiological flow conditions. IS also induced monocyte-mediated inflammation and ROS production in THP-1 cells. Phosphorylation of p38 MAPK and membrane translocation of NAD(P)H oxidase subunit p47phox in THP-1 cells were induced by IS. Both SB203580 (p38 MAPK inhibitor) and apocynin [NAD(P)H oxidase inhibitor] reduced THP-1 cell adhesion to HUVECs. Apocynin also inhibited IS-induced ROS production in THP-1 cells. IS induced monocyte-driven inflammation through NAD(P)H oxidase- and p38 MAPK-dependent pathways in monocytes. The main finding of this study was that AST-120 inhibited monocyte activation by reducing IS in vivo. This provides new insights on how AST-120 attenuates the progression of atherosclerosis in CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in animal models of renal dysfunction, the oral charcoal absorbent AST-120 significantly decreased necrotic areas and lessened aortic deposition of the uremic toxin indoxyl sulfate without affecting lesional macrophage or collagen content (73) while attenuating monocyte inflammation (74).”
From The contributory role of gut microbiota in cardiovascular disease (2014) · cites this paper as [74]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Integrins: A family of cell surface receptors
HYNES, R. (1987) · Cell · doi:10.1016/0092-8674(87)90233-9 · Cited by 4,249
Ronco, C., Haapio, M., House, A. A., Anavekar, N., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,883
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., & Massy, Z. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03980609 · Cited by 929
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa, T., & Ise, M. (1994) · PubMed · Cited by 440
NF-κB Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91
Anrather, J., Racchumi, G., & Iadecola, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506172200 · Cited by 386
Cited by
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
The contributory role of gut microbiota in cardiovascular disease
Tang, W. H. W., & Hazen, S. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72331 · Cited by 641
“…(72), and in animal models of renal dysfunction, the oral charcoal absorbent AST-120 significantly decreased necrotic areas and lessened aortic deposition of the uremic toxin indoxyl sulfate without affecting lesional macrophage or collagen content (73) while attenuating monocyte inflammation (74).”
BackgroundVaziri, N. D., Zhao, Y.-Y., & Pahl, M. V. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv095 · Cited by 394
“The salutary effects of AST-120 have been primarily attributed to its ability to limit formation and absorption of indoxyl sulfate [97, 98].”
BackgroundSallée, M., Dou, L., Cerini, C., Poitevin, S., Brunet, P., & Burtey, S. (2014) · Toxins · doi:10.3390/toxins6030934 · Cited by 255
“Increase in monocyte adhesion [92,94] Increase in monocyte adhesion [98,99]”
BackgroundInfluentialAltered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins
Lau, W. L., Savoj, J., Nakata, M. B., & Vaziri, N. D. (2018) · Clinical Science · doi:10.1042/cs20171107 · Cited by 237
Liu, W.-C., Tomino, Y., & Lu, K.-C. (2018) · Toxins · doi:10.3390/toxins10090367 · Cited by 194
“It induces free radical production, reduces nitric oxide levels, and activates AHR to produce ROS that damage cells.”
BackgroundInfluentialIto, S., & Yoshida, M. (2014) · Toxins · doi:10.3390/toxins6020665 · Cited by 174
“Moreover, treatment with indoxyl sulfate increased ROS production and induced the translocation of p47phox to the membranes of monocytic THP-1 cells [46].”
BackgroundSelf-citationKim, H. Y., Yoo, T., Hwang, Y., Lee, G. H., Kim, B., Jang, J., Yu, H. T., Kim, M. C., Cho, J., Lee, C. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03130-z · Cited by 144
The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS
Adesso, S., Popolo, A., Bianco, G., Sorrentino, R., Pinto, A., Autore, G., & Marzocco, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076778 · Cited by 126
“Therefore in addition to therapies, as antioxidant, aimed to reduce oxidative stress another interesting way would be to decrease the levels of pro-oxidant and proinflammatory uremic solutes, as IS in CKD patients by a very low protein dietary intake [59,60] or by oral adsorbent as AST-120 [61,62].”
BackgroundRole of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
Gao, H., & Liu, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.027 · Cited by 130
The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
Assem, M., Lando, M., Grissi, M., Kamel, S., Massy, Z. A., Chillon, J., & Hénaut, L. (2018) · Toxins · doi:10.3390/toxins10070303 · Cited by 128
“In line with this observation, IS has been reported to directly induce monocyte-mediated inflammation and ROS production in THP-1 monocytes via the NADPH oxidase and MAPK pathways [123] and display direct pro-inflammatory effects in vitro via activation of the NF-kB and MAPK pathways in macrophages differentiated from…”
BackgroundResultInfluentialKaminski, T. W., Pawlak, K., Karbowska, M., Myśliwiec, M., & Pawlak, D. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0457-1 · Cited by 118
“[28] used a nephrectomized mouse model to demonstrate that oral administration of IS activates numbers of proinflammatory functions and reactive oxygen species (ROS) production in monocytes.”
BackgroundVaziri, N. D., Yuan, J., Khazaeli, M., Masuda, Y., Ichii, H., & Liu, S. (2013) · American Journal of Nephrology · doi:10.1159/000351171 · Cited by 103
“The salutary effects of AST-120 have been primarily attributed to its ability to limit formation and absorption of indoxyl sulfate and p-cresol sulfate [25,26].”
BackgroundCrucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation
Ito, S., Osaka, M., Edamatsu, T., Itoh, Y., & Yoshida, M. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34462 · Cited by 119
Self-citationGut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
Glorieux, G., Gryp, T., & Perna, A. F. (2020) · Toxins · doi:10.3390/toxins12040245 · Cited by 107
“It is known that H2S is useful to the local gut bacteria because it increases bacterial resistance to antibiotics [53], it acts as a protective mechanism against ROS [54], and it provides bacterial resistance towards elimination by the host immune system [55].”
BackgroundInfluentialTMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 104
Secondary Immunodeficiency Related to Kidney Disease (SIDKD)—Definition, Unmet Need, and Mechanisms
Steiger, S., Rossaint, J., Zarbock, A., & Anders, H. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021091257 · Cited by 96
Edamatsu, T., Fujieda, A., & Itoh, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193342 · Cited by 81
The Chronic Kidney Disease—Colonic Axis
Pahl, M. V., & Vaziri, N. D. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12381 · Cited by 83
Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction
Aoki, K., Teshima, Y., Kondo, H., Saito, S., Fukui, A., Fukunaga, N., Nawata, T., Shimada, T., Takahashi, N., & Shibata, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002023 · Cited by 73
“A recent study showed that reduction of IS by AST120 can attenuate monocyte-mediated inflammation in renal dysfunction.(38) IS also stimulated expression of MCP-1 (a chemokine required for monocyte accumulation) in human umbilical vein endothelial cells by inducing oxidative stress.”
BackgroundHamano, H., Ikeda, Y., Watanabe, H., Horinouchi, Y., Izawa‐Ishizawa, Y., Imanishi, M., Zamami, Y., Takechi, K., Miyamoto, L., Ishizawa, K., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx252 · Cited by 65
“1% IS [200 mg (800 mmol)/kg/day] was administered to the mice in their drinking water for 2 weeks as previously described [19].”
MethodHénaut, L., Candellier, A., Boudot, C., Grissi, M., Mentaverri, R., Choukroun, G. J., Brazier, M., Kamel, S., & Massy, Z. A. (2019) · Toxins · doi:10.3390/toxins11090529 · Cited by 58
“The Procalcific Actions of Monocytes/Macrophages The pro-inflammatory cytokines released by M1 macrophages constitute an essential host defence component but can also cause important damage to the host itself.”
BackgroundMethodInfluentialTang, W.-H., Wang, C.-P., Chung, F., Huang, L. L. H., Yu, T., Hung, W., Lu, L.-F., Chen, P., Luo, C.-H., Lee, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119545 · Cited by 49
“IS has also been proven to be involved with free radical production and the elevation of inflammatory mediators [6,7,9].”
BackgroundGirndt, M., Trojanowicz, B., & Ulrich, C. (2020) · Toxins · doi:10.3390/toxins12050340 · Cited by 46
“oxidative stress [78], IS spurs leucocyte-endothelial-interactions and induces monocytic inflammation via p38 MAP kinases (mitogen activated protein kinases)—a central pathway triggering inflammatory cytokines such as IL-1ß and TNF-α [79].”
BackgroundInfluentialVasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins
Guo, J., Lu, L., Hua, Y., Huang, K. W., Wang, I., Huang, L., Fu, Q., Chen, A., Chan, P., Fan, H., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00787.2016 · Cited by 45
“It also ameliorated endothelial dysfunction, alleviated oxidative/nitrative stress in the aorta of subtotal nephrectomized rats (106), suppressed ROS production (137), inhibited monocyte activation by inducing monocyte-driven inflammation via NAD(P)H oxidase and p38 MAPK-dependent pathways, and retarded the progressio…”
BackgroundCardiorenal syndrome in chronic kidney disease
Tsuruya, K., & Eriguchi, M. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000099 · Cited by 48
Heart-kidney interactions: mechanistic insights from animal models
Liu, S. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00624.2017 · Cited by 43
“Oral administration of indoxyl sulfate activated proinflammatory function of peripheral blood monocytes in STNx mice (4, 54).”
BackgroundTargeting protein-bound uremic toxins in chronic kidney disease
Niwa, T. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.829456 · Cited by 43
“AST-120 inhibited monocyte activation by reducing indoxyl sulfate in vivo [89].”
BackgroundThe effect of activated charcoal on adenine-induced chronic renal failure in rats
Ali, B. H., Za’abi, M. A., Ramkumar, A., Al‐Lawati, I., Waly, M. I., Beegam, S., Nemmar, A., Brand, S., & Schupp, N. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.038 · Cited by 39
Hénaut, L., Grissi, M., Brazier, F., Assem, M., Poirot, S., Lenglet, G., Boudot, C., Avondo, C., Boullier, A., Choukroun, G. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42933-0 · Cited by 39
The Association of Uremic Toxins and Inflammation in Hemodialysis Patients
Hsu, H.-J., Yen, C.-H., Wu, I., Hsu, K., Chen, C., Sun, C., Chou, C., Chen, C., Tsai, C.-J., Wu, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102691 · Cited by 35
“Uremic toxins, especially proteinbound uremic toxins, are also considered to cause inflammation [13,14].”
Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages
Barisione, C., Garibaldi, S., Furfaro, A. L., Nitti, M., Palmieri, D., Passalacqua, M., Garuti, A., Verzola, D., Parodi, A., Ameri, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149276 · Cited by 39
“High IS levels, as found in end-stage CKD, have also been shown to affect monocyte/macrophage activation [14,15].”
BackgroundThe AKI-to-CKD Transition: The Role of Uremic Toxins
André, C., Bodeau, S., Kamel, S., Bennis, Y., & Caillard, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216152 · Cited by 42
He, T., Xiong, J., Huang, Y., Changling, Z., Liu, Y., Bi, X., Liu, C., Han, W., Yang, K., Xiao, T., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116570 · Cited by 38
Gases as Uremic Toxins: Is There Something in the Air?
Jankowski, J., Westhof, T., Vaziri, N. D., Ingrosso, D., & Perna, A. F. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.02.006 · Cited by 31
“In a more recent study, similar defects in gastric, jejunal, and ileal epithelial tight junctions in CKD animals were found.50 Endotoxemia commonly is present and is a major cause of inflammation in patients with advanced CKD.51 Because the epithelial tight junction is the main barrier against entry of endotoxin and o…”
BackgroundInfluentialNonextracorporeal Methods for Decreasing Uremic Solute Concentration: A Future Way To Go?
Meijers, B. K. I., Glorieux, G., Poesen, R., & Bakker, S. J. L. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.02.012 · Cited by 30
Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
Jha, P. K., Nakano, T., Itto, L. Y. U., Barbeiro, M. C., Lupieri, A., Aïkawa, E., & Aikawa, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1574489 · Cited by 34
Campillo, S., Bohórquez, L., Gutiérrez-Calabrés, E., García-Ayuso, D., Miguel, V., Griera, M., Calle, Y., de Frutos, S., Rodríguez-Puyol, M., Rodríguez-Puyol, D., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00738-8 · Cited by 31
Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis
Wakamatsu, T., Yamamoto, S., Yoshida, S., & Narita, I. (2024) · Toxins · doi:10.3390/toxins16060254 · Cited by 32
“…of cells to uremic IS concentrations (100–2000 µ M) results in various cellular dysfunctions and the expression of inflammatory cytokines [76,77], gives rise to nuclear factor (erythroid-2-related factor)-2 (Nrf2) downregulation [78], and promotes the differentiation of macrophages towards…”
BackgroundProtein-Bound Uremic Toxins and Immunity
Rocchetti, M. T., Cosola, C., Ranieri, E., & Gesualdo, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1507-2_15 · Cited by 28
Hwang, Y.-J., Yun, M.-O., Jeong, K.-T., & Park, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.027 · Cited by 26
Sato, E., Tanaka, A., Oyama, J., Yamasaki, A., Shimomura, M., Atsushi, H., Ueda, Y., Amaha, M., Nomura, M., Matsumura, D., et al. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0785-7 · Cited by 30
Classification of Five Uremic Solutes according to Their Effects on Renal Tubular Cells
Edamatsu, T., Fujieda, A., Ezawa, A., & Itoh, Y. (2014) · International Journal of Nephrology · doi:10.1155/2014/512178 · Cited by 22
“Indoxyl sulfate (IS) is a representative protein-bound solute and its deleterious effects have been studied in various cell types including renal tubular cells [9], mesangial cells [10], vascular endothelial cells [11], vascular smooth muscle cells [12], osteoclasts [13], osteoblasts [14], erythrocytes [15], and monoc…”
BackgroundLi, X., Lu, Z., Zhou, F., Jin, W., Yang, Y., Chen, S., Xie, Z., & Zhao, Y. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106763 · Cited by 19
Tsai, L.-T., Weng, T., Chang, T.-Y., Lan, K., Chiang, C., & Liu, S. (2023) · Antioxidants · doi:10.3390/antiox12111931 · Cited by 18
“Moreover, AST-120 addresses CKD-related inflammation by inhibiting immune cell activation, oxidative stress, and inflammatory responses [69,70].”
BackgroundToward Human Models of Cardiorenal Syndrome in vitro
Gabbin, B., Meraviglia, V., Mummery, C. L., Rabelink, T. J., van Meer, B. J., van den Berg, C. W., & Bellin, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.889553 · Cited by 18
Zhang, Y., Yin, N., Sun, A., Wu, Q., Hu, W., Hou, X., Zeng, X., Zhu, M., & Liao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602703 · Cited by 16
“Reduction of the Na/K-ATPase and APQ1 is closely connected with kidney function and has been proposed to promote fibrosis and increase metabolites and uremic toxin (Rajasekaran et al., 2010; Liu et al., 2012; Ito et al., 2013).”
BackgroundOral adsorbents for preventing or delaying the progression of chronic kidney disease
Wu, H. M., Sun, H. J., Wang, F., Yang, M. J., Dong, B. R., & Liu, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007861.pub2 · Cited by 17
Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
Kishimoto, H., Nakano, T., Torisu, K., Tokumoto, M., Uchida, Y., Yamada, S., Taniguchi, M., & Kitazono, T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.990422 · Cited by 13
ALTUNKAYNAK-CAMCA, H. O., Karaismailoğlu, E., & Massy, Z. A. (2024) · Toxins · doi:10.3390/toxins16120544 · Cited by 11
Animal Models for Studying Protein-Bound Uremic Toxin Removal—A Systematic Review
Ahmed, S., de Vries, J. C., Lu, J., Stuart, M. H. V., Mihaila, S. M., Vernooij, R. W. M., Masereeuw, R., & Gerritsen, K. G. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713197 · Cited by 6
Rahman, W. K., Al-Diwaniyah Health Office, M. O. H. A. E., Rabeea, I. S., & Meizel, M. M. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0128 · Cited by 10
Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas
Shih, Y.-C., Wu, C., Wang, S., Liou, J., Huang, P., & Tarng, D. (2020) · Toxins · doi:10.3390/toxins12040237 · Cited by 7
“Uremic serum also introduces adhesion of monocytes to the endothelium, and AST-120 could mitigate the adhesion of monocytes [10].”
BackgroundAoyama, J., Osaka, M., Deushi, M., Hosoya, S., Ishigami, A., Maehara, T., & Yoshida, M. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63237 · Cited by 6
Self-citationCutaneous adaptive immunity and uraemia: a narrative review
Zibandeh, N., Li, Z., Ogg, G. S., & Bottomley, M. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1464338 · Cited by 8
NEK7 mediates ESRD-associated endothelial injury by activating the NLRP3 inflammasome
Sun, L., Ren, Y., Zhu, W., Ni, T., Huang, S., Zhang, A., Zhang, Y., Hu, H., Jia, Z., & Sun, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115236 · Cited by 7
Carmona, A., Guerrero, F., Muñoz-Castañeda, J. R., Jimenez, M. J., Rodríguez, M., Soriano, S., & Martín‐Malo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612938 · Cited by 5
Karbowska, M., Kaminski, T. W., & Pawlak, D. (2016) · Toxin Reviews · doi:10.1080/15569543.2016.1222442 · Cited by 4
“Additionally, AST-120 exerts antioxidants effect (Nishikawa et al., 2015; Shimoishi et al., 2007) and reduces monocyte-mediated inflammation in renal failure (Ito et al., 2013) (confirmed in experiments using animal models and cell cultures).”
BackgroundJang, H. R., Cho, H. J., Zhou, Y., Shao, N., Lee, K., Le, H. H. T., Jeon, J., Lee, J. E., Huh, W., Ong, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.618796 · Cited by 5
“Indoxyl sulfate andAGEwere reported to increase cardiovascular risk in CKD (Wang et al., 2005; Ito et al., 2013; Barisione et al., 2015).”
BackgroundEditorial: A missing link? Monocyte activation by uremic toxins in cardiorenal syndrome
Armstrong, E. J., Granick, J. L., & Simon, S. I. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113037 · Cited by 3
Roth-Stefanski, C. T., Dolenga, C. J. R., Nakao, L. S., Pecoits‐Filho, R., de Moraes, T. P., & Moreno-Amaral, A. N. (2019) · Current Nutrition & Food Science · doi:10.2174/1573401315666190215111402 · Cited by 3
Ohtake, T., Mochida, Y., Ishioka, K., Moriya, H., Hidaka, S., Hirata, M., Yamada, H., Kumagai, H., & Kobayashi, S. (2020) · Renal Replacement Therapy · doi:10.1186/s41100-020-00276-x · Cited by 2
“IS accumulates along with renal dysfunction and induces endothelial dysfunction via monocyte activation [4] and oxidative stress [5, 6].”
BackgroundROLE OF ACTIVATED CHARCOAL IN LIMITING THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN ALBINO RATS
El-Kafoury, B. M. A., Saleh, N., Saad, D. A., Shawky, M., Mehanna, N. S., & Ghonamy, E. (2019) · Al-Azhar Medical Journal · doi:10.21608/amj.2019.50729 · Cited by 3
“…attributed to the charcoal's ability to limit formation and absorption of indoxyl sulphate hence alleviating the overload of indoxyl sulphate on proximal tubular epithelial cells and podocytes ROLE OF ACTIVATED CHARCOAL IN LIMITING THE PROGRESSION… (Shimizu et al., 2011 and Ito et al., 2013).”
BackgroundIndoxyl Sulfate and Arteriosclerosis
Nakano, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-7793-2_6 · Cited by 2
Quante, M. (2015) · Transplantation · doi:10.1097/tp.0000000000000793
“Of note, in a CKD animal model, reduced serum indoxyl sulfate levels after oral adsorbent application have in turn been shown to impact immune responses by attenuating monocyte inflammation, a key driver in the development of atherosclerosis.(8)”
BackgroundHUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
Munteanu, A. M., Cursaru, R., Guja, L., Carniciu, S., Borcan, A. M., & Popescu‐Spineni, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.3.2
Shin, D. H., Park, K., Yang, J. W., & Lee, J. Y. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22091365
“Additionally, in vivo study demonstrated that SAC inhibits monocyte activation, a crucial factor in the progression of atherosclerosis [27].”
Patrier, L. (2014) · theses.fr (ABES) · doi:10.70675/856fba23zd92az4508z88b4z4a6cd1d739dd
Brain‐Kidney Axis Dysfunction in Intracerebral Hemorrhage: Mechanisms and Interventions
Chen, Y., Guo, R., Wang, Y., Zhao, Z., Chen, L., Zhang, Y., Xu, F., Wei, L., Chen, G., Yang, G., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202601498rrr
“In addition, the oral adsorbent AST-120 reduces circulating IS levels via targeted clearance of this toxin, thereby improving brain-kidney axis-related outcomes [81].”
Metadata
- Authors
- Ito, S., Higuchi, Y., Yagi, Y., Nishijima, F., Yamato, H., Ishii, H., Osaka, M., & Yoshida, M.
- Affiliations
- Tokyo Medical and Dental University (JP)
- Kureha (Japan) (JP)
- Corresponding author
- Yoshida, Masayuki
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-29
- Volume
- 93
- Issue
- 6
- Pages
- 837-845
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2116667963
- Cited by
- 72
- References
- 47
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 8 · 2014: 11 · 2013: 5
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- AST-120, indoxyl sulfate, chronic kidney disease, monocyte activation, monocyte inflammation, monocyte adhesion, NADPH oxidase, p38 MAPK, reactive oxygen species, Mac-1, atherosclerosis, cardiovascular disease, oral adsorbent, apocynin, SB203580
- MeSH terms
- Animals, Carbon, Cardiovascular Diseases, Cell Line, Disease Models, Animal, Flow Cytometry, Gastrointestinal Agents, Humans, Indican, Inflammation, Male, Mice, Inbred C57BL, Monocytes, Oxides, Immunoblotting, Reactive Oxygen Species, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.